Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties

被引:141
作者
Scozzafava, A
Menabuoni, L
Mincione, F
Supuran, CT
机构
[1] Univ Florence, Lab Chim Inorgan & Bioinorgan, I-50121 Florence, Italy
[2] Univ Florence, CSGI, I-50121 Florence, Italy
[3] Osped Pescia, UO Oculist Az, Val di Nievole, Pescia, Italy
[4] Univ Florence, Inst Ophthalmol, I-50134 Florence, Italy
[5] Osped San Giovanni di Dio, UO Oculist, I-50123 Florence, Italy
关键词
D O I
10.1021/jm0108202
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Reaction of polyamino-polycarboxylic acids or their dianhydrides with aromatic/heterocyclic sulfonamides possessing a free amino/imino/hydrazino/hydroxy group afforded mono- and bis-sulfonamides containing polyamino-polycarboxylic acid moieties in their molecule. The acids/ anhydrides used in synthesis included IDA, NTA, EDDA, EDTA and EDTA dianhydride, DTPA and DTPA dianhydride, EGTA and EGTA dianhydride, and EDDHA, among others. All the newly prepared derivatives showed strong affinity toward isozymes I, II, and IV of carbonic anhydrase (CA). Metal complexes of the new compounds have also been prepared. Metal ions used in such preparations included di- and trivalent main-group and transition cations, such as Zn(II), Cu(II), Al(III), etc. Some of the new sulfonamides/disulfonamides obtained in this way, as well as their metal complexes, behaved as nanomolar CA inhibitors against isozymes II and IV, being slightly less effective in inhibiting isozyme I. Some of these sulfonamides as well as their metal complexes strongly lowered intraocular pressure (IOP) when applied topically, directly into the normotensive/glaucomatous rabbit eye, as 1-2% water solutions/ suspensions. The good water solubility of these sulfonamide CA inhibitors, correlated with the neutral pH of their water solutions used in the ophthalmologic applications and the long duration of action of the IOP-lowering effect, makes them interesting candidates for developing novel types of antiglaucoma drugs devoid of serious topical side effects.
引用
收藏
页码:1466 / 1476
页数:11
相关论文
共 50 条
[31]   Carbonic anhydrase inhibitors: Topical sulfonamide antiglaucoma agents incorporating secondary amine moieties [J].
Renzi, G ;
Scozzafava, A ;
Supuran, CT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (07) :673-676
[32]  
Schwartzenberg GWST, 1999, CAN J OPHTHALMOL, V34, P93
[33]   Carbonic anhydrase inhibitors: Synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties [J].
Scozzafava, A ;
Menabuoni, L ;
Mincione, F ;
Mincione, G ;
Supuran, CT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (04) :575-582
[34]   Carbonic anhydrase activators - Part 21. Novel activators of isozymes I, II and IV incorporating carboxamido and ureido histamine moieties [J].
Scozzafava, A ;
Supuran, CT .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (01) :31-39
[35]   Carbonic anhydrase inhibitors. Part 74. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: Is the tail more important than the ring? [J].
Scozzafava, A ;
Menabuoni, L ;
Mincione, F ;
Briganti, F ;
Mincione, G ;
Supuran, CT .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (14) :2641-2650
[36]   Carbonic anhydrase inhibitors: Synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route [J].
Scozzafava, A ;
Briganti, F ;
Mincione, G ;
Menabuoni, L ;
Mincione, F ;
Supuran, CT .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (18) :3690-3700
[37]   Carbonic anhydrase inhibitors: Perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action [J].
Scozzafava, A ;
Menabuoni, L ;
Mincione, F ;
Briganti, F ;
Mincione, G ;
Supuran, CT .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) :4542-4551
[38]   PHARMACOKINETICS, ACID-BASE-BALANCE AND INTRAOCULAR-PRESSURE EFFECTS OF ETHYLOXALOYLAZOLAMIDE - A NOVEL TOPICALLY ACTIVE CARBONIC-ANHYDRASE INHIBITOR [J].
SHARIR, M ;
PIERCE, WM ;
CHEN, D ;
ZIMMERMAN, TJ .
EXPERIMENTAL EYE RESEARCH, 1994, 58 (01) :107-116
[39]   Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt®) [J].
Silver, LH .
SURVEY OF OPHTHALMOLOGY, 2000, 44 :S147-S153
[40]   CATALYTIC MECHANISM OF CARBONIC-ANHYDRASE - HYDROGEN-ISOTOPE EFFECTS ON KINETIC-PARAMETERS OF HUMAN C ISOENZYME [J].
STEINER, H ;
JONSSON, BH ;
LINDSKOG, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1975, 59 (01) :253-259